Introduction
Mediastinal endosonography-guided aspiration has anteceded surgical staging as the step of choice for the diagnosis of mediastinal tissue disorders. Aim This study aimed to evaluate the diagnostic efficacy and safety of either endobronchial ultrasound combined with transbronchial needle aspiration (EBUS-TBNA) or transesophageal bronchoscopic ultrasound-guided fine-needle aspiration (EUS-FNA-B/E) in evaluating and biopsying the subcarinal region (station 7).
Patients and methods
Seventy-seven patients with enlarged subcarinal lymph nodes 'short axis more than or equal to 1 cm' as a preliminary station were divided randomly into two groups: group I included patients evaluated by EBUS-TBNA and group II included patients evaluated by EUS-FNA-B/E. The specimens were examined using the Rapid On Site Evaluation technique and then confirmed by the final histopathological and immunohistochemical evaluation.
Results
Fifty-one men and 26 women, mean±SD age (51.12±10.15 years), were divided into two groups. In group I, the mean±SD time spent during the procedure was 32.49±9.48 min, the mean±SD number of aspirations was 3.07±0.72, and the mean ±SD O 2 saturation was 83.59±4.34%; therefore, the mean±SD supplementary oxygen was 3.78±1.04 l/min. However, in group II, these values were 22.05 ±6.39 min, 2.00±0.67, 91.66±3.09%, and 1.71±1.19 l/min, respectively, with a significant difference. The sensitivity, negative predictive value, and diagnostic accuracy of EBUS-TBNA in diagnosing malignant lesions were 88, 67, and 90%, which were significantly less than those of EUS-FNA-B/E: 93, 86, and 95%, respectively. No severe complications were encountered with the use of both techniques.
Conclusion
The study recommends the usage of EUS-FNA-B/E than EBUS-TBNA in evaluating and biopsying the subcarinal region because of its better tolerability, higher Introduction Endosonography has gained a valuable role in the diagnosis and prognosis of respiratory diseases over the last decades including endobronchial ultrasound (EBUS) and endoscopic ultrasound (EUS). Staging of mediastinal lymph node has an effect on the decision of the management of patients with either operable or inoperable cancers of the lung (e.g. surgery vs. combined chemoradiation therapy) [1] . International lung cancer staging guidelines have recently stated that endosonography should precede the surgical staging in the evaluation and sampling of tissues [2] . EBUS and EUS have an integrated diagnostic yield; thus, when combined, all mediastinal lymph nodes substantially can be biopsied [3] .
The accessible lymph node stations for EBUS combined with transbronchial needle aspiration (EBUS-TBNA) are 2L/R, 3, 4L/R, 7, 10L/R, an 11L/R, whereas those for EUS fine-needle aspiration (EUS-FNA) are 2L/R, 3p, 4L/R, 5, 6, 7, 9, and 10L/R and infra-diaphragmatic sites of potential distant metastases (left adrenal, left liver lobe, celiac lymph nodes). Therefore, some lymph node stations can be evaluated by both procedures, especially the subcarinal region (station 7), the often affected one, and the left lower paratracheal region (station 4 l) [4] .
This study aims to evaluate the diagnostic efficacy and safety of either EBUS-TBNA or transesophageal bronchoscopic ultrasound-guided FNA (EUS-FNA-B/E) in evaluating and biopsying the subcarinal region (station 7).
Patients and methods
The data for this prospective randomized comparative study were collected between December 2017 and September 2018 at the endoscopy unit of Tanta University International Educational Hospital. Eighty-two patients with enlarged subcarinal lymph nodes (station 7) as a preliminary station with no enlarged ipsilateral N1 lymph nodes (from station 10 up to station 14) were enrolled in this study; otherwise, EBUS-TBNA was performed from N1 nodes and then from N2 nodes (as subcarinal lymph node) to avoid contamination and upstaging by false-positive results.
The patients underwent either EBUS or the EUS technique, which was carried out by the same operator and the same bronchoscope (either procedure was chosen in a randomized manner by closed envelops). Patients who underwent EBUS-TBNA and then underwent EUS-FNA-B/E for confirmation of the diagnosis or the reverse; EUS-FNA-B/E then EBUS-TBNA; were also included in the study and the histopathological results were added to the value of either diagnostic technique. Any N2 additional lymph node stations examined by EBUS or EUS (not accessible by EBUS) were evaluated and biopsied, but not added to the diagnostic performance of either maneuver as this was beyond the scope of this study. The short axis of the subcarinal lymph node had to be 1 cm or more on the thoracic computed tomography scan for inclusion in this study. All patients with endobronchial lesions, cardiovascular instability, bleeding diathesis (international normalized ratio>1.3 or platelet count <50 000/ mm 3 ), and border line respiratory failure, and patients who could not cooperate were excluded. Heart rate, rhythm, respiratory rate, arterial blood pressure, and transcutaneous oxygen saturation were monitored continuously during both procedures.
A written informed consent was obtained from every patient included in this study after a simplified explanation of the indication, the application, and the possible complications of the maneuver was provided, and the study protocol was approved by the Research Ethics Committee, Faculty of Medicine, Tanta University.
Endobronchial ultrasound-transbronchial needle aspiration EBUS-TBNA was performed using a convex probe (HI VISION Avius; Hitachi Company, Tokyo, Japan) '7.5 MHz' incorporated into the tip of a dedicated fiber-optic bronchoscope (Pentax EPK-i5000, Tokyo, Japan). The procedure was performed in the supine position by the oral route under local anesthesia with a 2% lidocaine spray to the posterior oropharynx and the larynx, and under moderate sedation (9.23±3.42 mg midazolam (range, 5-15 mg). The oxygen saturation was maintained to be not less than 90% during the procedure; if O 2 desaturation occurred, supplementary oxygen was added and then the procedure was restarted again. A routine examination of all patients' airways was first performed to exclude any endobronchial lesions. Then, the lymph node stations were identified in accordance with Mountain's regional lymph node classification system [5] .
The real-time EBUS B mode assessed the targeted lymph node (its inferior border is the superior border of the lower lobe bronchus on the left side, and it is the inferior border of the intermediate bronchus on the right side) [6] according to its size, shape, echogenicity, and margin, and color Doppler ultrasound was used to assess the vessels around and to avoid puncture of any surrounding vascular structure. A dedicated needle, 22 G (ECHO-HD, 22-EBUS P, Echotip, Ultra, COOK, Limerick, Ireland), was inserted to obtain the cellular aspirate materials.
Endoscopic ultrasound-fine-needle aspiration-B/E
The same EBUS bronchoscope was inserted gently through the esophagus. The vascular landmarks were assessed to evaluate the site of the subcarinal lymph node (the node lies just dorsal to the origin of the left pulmonary artery and cranial to the left atrium) [6] . The same-sized needle was used to obtain the aspirate specimens through the esophageal wall.
Preparation of the specimens
After preparation of air-dried smears and immediately placing them on glass slides in 95% ethyl alcohol, hematoxylin and eosin staining was performed for immediate histopathological examination using the Rapid On Site Evaluation (ROSE) technique. For cell block preparation, any remaining blood clot was pushed in the test tube, centrifuged for 10 min, and then fixed in 10% formalin overnight forming cell button. The prepared cell button was processed as a routine biopsy specimen, followed by hematoxylin and eosin staining.
For immunohistochemical staining, in brief, the sections were subjected to dewaxing, inactivation of endogenous peroxidase activity, and cross-reactivity blocking with normal serum (Vectastain Elite Kit; Vector, Burlingame, California, USA), followed by overnight incubation at 4°C with a diluted solution of the primary antibodies (CD15, CD20, CD30, P63, Pan CK, chromogranin, and TTF1) (Labvision UK, according to the manufacturers' instructions). The location of the primary antibodies was determined using a biotinylated anti-primary antibody. The slides were counter-stained by hematoxylin.
The comparing parameters
The final histopathological and then immunohistochemical diagnosis was the gold standard for the decision on the diagnostic efficacy of the procedure. A definitivediagnosisofbenignlesionswasmadeonthebasis of specimens showing specific benign tumors, granulomatous inflammation with or without caseous necrosis, or positive microbiological studies. Any complication encountered during both maneuvers was reported. Other parameters such as the shape and size of the lymph node, identification of the borders of the lymph node [2] and its vascular landmarks easily and obviously to avoid mistaking with other stations, O 2 desaturation during the procedure, time spent in performing the maneuver (from entry up to biopsying subcarinal lymph nodes), and the number of TBNA punctures were analyzed.
Statistical analysis
Quantitative data were presented as mean±SD. Qualitative data were expressed as frequency and percentage. Statistical analyses were carried out using SPSS software (version 17.0; SPSS Inc., Chicago, Illinois, USA). Statistical significance was considered when the comparative P value less than 0.05. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy rate were analyzed using the standard definitions.
Results
The study included 77 patients; 51 of these patients were men and 26 were women (the male : female ratio was 66 : 34%, mean±SD age 51.12±10.15 years (range, 28-69 years)). The patients were distributed randomly into two groups (41 cases in each as there were five patients involved in both groups). Group I included patients who underwent biopsy of the subcarinal lymph nodes through the EBUS-TBNA technique, whereas group II included patients who underwent biopsy through the EUS-FNA-B/E technique.
The mean±SD short axis of lymph node in group I was 18.20±4.31 mm (range, 12-28 mm) and that in group II was 19.29±4.30 mm (range, 11-26 mm), with no significant difference (P=0.252) ( Table 1 ). The superior and inferior borders of the lymph nodes were assessed by EBUS in 35 (85.4%) cases, and they were assessed by EUS in 32 (78%) cases, with no significant difference (P=0.391) ( Figure 1 ).
The mean±SD time spent in the EBUS-TBNA technique was 32.49±9.48 min (range, 18-50 min), which was significantly higher than that spent in the EUS-FNA technique of 22.05±6.39 min (range, 12-35 min) (P=0.001). The mean±SD number of aspirations in group I was 3.07±0.72 (range, 2-4), whereas in group II, it was 2.00±0.67 (range, 1-3) (P=0.001). The mean±SD O 2 saturation recorded in group I was 83.59±4.34% (range, 76-91%), whereas in group II, it was 91.66±3.09% (range, 87-96%) (P=0.001); therefore, the mean±SD need for supplementary oxygen during the procedure was 3.78±1.04 l/min (range, 2-6 l/min) in patients who underwent EBUS-TBNA, which was significantly higher than that needed for patients who underwent EUS-FNA-B/E: 1.71±1.19 l/min (range, 0-3 l/min) (P=0.001) ( Table 1) .
In group I, the ROSE technique yielded 28 malignant lesions, nine benign, and four cases were considered to have a nonspecific diagnosis (just bronchial mucosa, chronic inflammation, and necrosis). The final histopathological and immunohistochemical studies yielded 29 definitive malignant diagnoses, eight benign lesions (two cases from the benign group changed to malignant and one malignant case was confirmed to be benign), and the same four inadequate cases (the cases were repeated by EUS-FNA-B/E and pathological proof was confirmed in three of them and the last was diagnosed by mediastinoscopy). In group II, the ROSE technique yielded 27, 12, and two malignant, benign, and inadequate results; on histopathological confirmation, one benign case was diagnosed as malignant and one malignant case was diagnosed as benign to be counted as such. For the two inadequate cases, one was diagnosed by EBUS-TBNA and the other was the same failed to be diagnosed by EBUS-TBNA and diagnosed by mediastinoscope). The ROSE results, and the final pathological and immunohistochemical diagnoses of all cases are reported in (Table 2) . (Figures 2 and 3 ).
No major complications were observed in both techniques: only minor hemorrhage after biopsy in two cases in group I, which stopped after a few minutes, and one patient in group II reported lowgrade fever (37.8°C) that lasted for only the first 24 h after the procedure.
Discussion
EBUS-TBNA does not have the ability to reach all mediastinal lymph nodes. A complementary role of EBUS-TBNA and EUS-FNA can provide a more precise and systematic evaluation of the mediastinal tissue [7] . However, practically, this combination may be obstructed as EUS-FNA requires expert endoscopists and expensive equipment, increasing the medical costs and the time required for evaluation. Therefore, it may be better if both procedures are performed sequentially, in the same setting, by the same operator using the same EBUS bronchoscope [8] [9] [10] . Actually, the reach of EUS-FNA-B/E and EBUS-TBNA is partly overlapping and partly complementary. EBUS-TBNA follows the main airways, whereas EUS-FNA-B/E is optimum for the evaluation of the left and lower mediastinal stations, especially the paraesophageal ones [6] .
The subcarinal region (station 7) is one of the stations that can be evaluated and biopsied by both EBUS and EUS [6] . In comparing the view of each procedure, in EUS, the lymph nodes are described relating to vascular structures (the node lies dorsal to the origin of the left pulmonary artery and cranial to the left atrium) [11] , but with a larger ultrasound window angle (150-180°with EUS vs. 50-60°with EBUS), which makes the identification of ultrasound landmarks as large vessels easier with EUS. In contrast, the available bronchoscopic view of EBUS into the airways enables the obvious identification of the lymph node station [12] .
In terms of the identification of the borders of the lymph node, its inferior border is difficult to delineate by EUS. With EUS-FNA, the subcarinal nodes are located exactly above the left atrium. The left atrium or the pulmonary artery is variably related to the bronchus intermedius and the left lower lobe bronchus (the latter being the newly defined inferior borders of station 7). With EBUS-TBNA, the inferior border can be possibly delineated because it allows a simultaneous bronchoscopic view, although there are no distinct corresponding ultrasound landmarks [6] . In this study, the definition of the inferior border of lymph node by EBUS or EUS was acceptable [35 (85.4%) cases and 32 (78%) cases, respectively, with no significant difference].
The demarcation of borders of the lymph node either with EBUS-TBNA or with EUS-FNA-B/E is an important step in diagnosis and subsequently prognosis as hilar nodes (station 10) − located medial to the main bronchi − can be overinterpreted as subcarinal nodes that would lead to an upstaging of the patient (from N1 to N2 stage), with definitely different therapeutic and prognostic consequences [13] .
The mean±SD short axis of the lymph node included in this study was 18.20±4.31 mm in group I (range, 12-28 mm) and 19.29±4.30 mm in group II (range, 11-26 mm) . This was in agreement with former studies that stated that cut-off values for the short-axis diameter of lymph node of 10-15 mm had a high probability to define abnormality [14] .
On comparing the tolerability of each procedure, no coughing was remarkable during EUS, whereas coughing was the most discomfort feeling during EBUS; this observation was in agreement with that of Yıldırım et al. [15] , who reported the rate to be 61.1% in the EBUS group. Also, Steinfort and Irving [16] investigated the patients' discomfort under conscious sedation during EBUS-TBNA and found that coughing was the most common complaint (71%) in their study.
Sequentially, the mean±SD time spent in EUS-FNA-B/E was 22.05±6.39 min, which was significantly less than that spent in EBUS-TBNA (32.49±9.48) (P=0.001); the mean±SD number of needle punctures per lymph node was significantly less in EUS-FNA-B/E (2.00±0.67) than EBUS-TBNA (3.07±0.72) (P=0.001); O 2 desaturation (SpO 2 <90%) was remarkable in EBUS than in EUS, as documented by Douglas et al. [17] , who described five main causes of oxygen desaturation in patients undergoing EBUS under conscious sedation: hypoventilation, V/Q mismatch, shunt, hypoxic mixture, and diffusion impairment. Thus, patients in group I were in need of supplementary oxygen (3.78 ±1.04 l/min) that was significantly higher than that in group II. Conclusively, EUS was more tolerable than EBUS for evaluating the subcarinal region.
The sensitivity, specificity, PPV, NPV, and diagnostic accuracy of EBUS-TBNA were 88, 100, 100, 67, and 90%, respectively, whereas those of EUS-FNA-B/E were 93, 100, 100, 86, and 95%, respectively. These results were in agreement with those of Lee et al. [18] , who documented that the sensitivity, specificity, PPV, NPV, and accuracy of EBUS-TBNA were 79.3% (23/ 29), 100% (8/8), 100% (23/23), 57.1% (8/14), and 83.7% (31/37), respectively. Also, Gu et al. [19] reported that this procedure had a sensitivity of 93% and a specificity 100%, but for EUS-FNA-B/E, most of the studies stated their complementary and not the alternative diagnostic role as the combined procedure EBUS-TBNA then EUS-FNA-B/E using the same ultrasonic bronchoscope afforded advantages as stated by Herth et al. [9] , who reported a sensitivity of 96% and NPV of 96% on 619 lymph nodes.
Because cytoaspirations may be false negative because of factors such as detection of lymph node, sampling procedure, or interpretation error, we used rapid on site cytopathological evaluation (ROSE) to increase the diagnostic yield and to decrease the number of lymph node punctures as documented with other studies [20, 21] . Finally, the cell block technique and formalin fixation of core particles have improved the final histopathological results [22] . The samples obtained by both procedures allowed immunostaining in about 86.2% of malignant cases by EBUS-TBNA and 88.9% by EUS-FNA-B/E, which were in agreement with Kerr [23] , who reported that both EUS-guided and EBUS-guided biopsies allow immunostaining in about 80-90% of cases and this is important for subtyping of nonsmall cell lung cancer, lymphoma, and differential diagnosis to metastases and mesothelioma and for the diagnosis of parenchymal granulomatous diseases.
There were no severe complications or mortality rate in this study either by EBUS-TBNA or by EUS-FNA-B/E. In general, endosonography-guided biopsies have an extremely low complication rate and are therefore considered to be safe and minimally invasive [24] . Severe adverse events were reported in only 0.3% of EUS-FNA and in 0.05% of EBUS-TBNA [25] . A nationwide survey (89 hospitals in the Netherlands) reported that 25 severe adverse events had occurred among 14 075 cases who underwent EUS-FNA and 2675 cases who underwent EBUS-TBNA (0.15%, EUS-FNA: 0.16% and EBUS-TBNA: 0.11%), and most of them were of infectious origin [26] .
The limitations of this study included, first, the small sample size, which does not enable absolute confirmation of the validity of our results, second, we did not use a scaling system such as a visual analog scale to evaluate the patients' discomfort and anxiety during the procedures and we depended on the operator's observability, third, the failed cases to be diagnosed by either technique were repeated by the other one before the decision of more invasive maneuver as mediastinoscope that may create a selection bias, and finally, the study did not focus on the interobserver variability between pathologists, which should be taken into consideration. A recent study documented a moderate level of agreement between a group of pathologists in subtyping 96 cases of NSCLC histology specimens as the interobserver (dis)agreement was a kappa of 0.55 (95% confidence interval, 053-0.58) [27] .
Conclusion and recommendations
The study recommends the use of EUS-FNA-B/E than EBUS-TBNA in evaluating and biopsying the subcarinal region (in the case of being the preliminary lymph node) because of its better tolerability, higher diagnostic yield, and lower complication rate.
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